Ian has a consistent international track record of growing revenues, profits, and market shares through application of creative business models and marketing fundamentals. Having lived and worked in different countries, he truly understands the importance of understanding the different customer needs and market dynamics from market to market, if companies are to maximize brand acceptance and sales results.

Ian has held a number of senior marketing roles for global medical device companies. These most recently include Integrum, a Swedish company pioneering the concept of osseointegration as a transformational technology for amputees where he was VP Global Marketing, with a particular focus on establishing the technology as an enabling and disruptive alternative to the traditional method of amputee use of socket technologies.

As Director of Strategy for Robotics at Zimmer Biomet, Ian led the market entry planning, and commercialization, for the company’s Orthopedic robotic platform. This included developing a customer segmentation strategy as well as recruiting and leading a team of Clinical Program Managers to accelerate market adoption and ensure early customer success.

He was SVP Marketing for Mako Surgical Corp, which was acquired in 2013 by Stryker, where he refocused the marketing efforts on the key surgeon audience as well as C-Suite and patient customers. Previously, he was VP Marketing for Smith & Nephew’s North American Wound Management business where he successfully led the turnaround marketing efforts for the device and dressing portfolios that had been underperforming compared to competitive peers.

In addition to working for established companies Ian has also worked for several startups including Idexx, now the global leader in animal health diagnostics, where he was responsible for European distributor management and part of the team that set up the UK subsidiary.

Ian has consulted for several blue chip and startup companies in the life sciences market, particularly in the areas of orthopaedics, robotics, wound management, diagnostics, and surgical devices – covering capital, implantable and disposable products.